Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion
- PMID: 11486172
- DOI: 10.1053/hupa.2001.25586
Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion
Abstract
This report investigates the pathomechanism of acute renal failure caused by toxic acute tubular necrosis after treatment with the antiretroviral agent adefovir. A 38-year-old white homosexual man with human immunodeficiency virus infection and no history of opportunistic infections was maintained on highly active antiretroviral therapy (HAART), including hydroxyurea, stavudine, indinavir, ritonavir, and adefovir dipivoxil. Histologic examination of the renal biopsy showed severe acute tubular degenerative changes primarily affecting the proximal tubules. On ultrastructural examination, proximal tubular mitochondria were extremely enlarged and dysmorphic with loss and disorientation of their cristae. Functional histochemical stains for mitochondrial enzymes revealed focal tubular deficiency of cytochrome C oxidase (COX), a respiratory chain enzyme partially encoded by mitochondrial DNA (mtDNA), with preservation of succinate dehydrogenase, a respiratory chain enzyme entirely encoded by nuclear DNA (nDNA). Immunoreactivity for COX subunit I (encoded by mtDNA) was weak to undetectable in most tubular epithelial cells, although immunoreactivities for COX subunit IV and iron sulfur subunit of respiratory complex III (both encoded by nDNA) were well preserved in all renal tubular cells. Single-renal tubule polymerase chain reaction revealed marked reduction of mtDNA in COX-immunodeficient renal tubules. We conclude that adefovir-induced nephrotoxicity is mediated by depletion of mtDNA from proximal tubular cells through inhibition of mtDNA replication. This novel form of nephrotoxicity may serve as a prototype for other forms of renal toxicity caused by reverse transcriptase inhibitors.
Copyright 2001 by W.B. Saunders Company.
Comment in
-
Adefovir nephrotoxicity and mitochondrial DNA depletion.Hum Pathol. 2002 May;33(5):574. doi: 10.1053/hupa.2002.124012. Hum Pathol. 2002. PMID: 12094387 No abstract available.
Similar articles
-
Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy.Kidney Int. 1994 May;45(5):1388-96. doi: 10.1038/ki.1994.181. Kidney Int. 1994. PMID: 8072250
-
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney Int. 2010 Dec;78(11):1171-7. doi: 10.1038/ki.2010.318. Epub 2010 Sep 1. Kidney Int. 2010. PMID: 20811330
-
Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.Antivir Ther. 2006;11(1):79-86. Antivir Ther. 2006. PMID: 16518963
-
Adefovir dipivoxil: focus on its use in the treatment of chronic hepatitis B.Rev Gastroenterol Disord. 2005 Spring;5(2):89-100. Rev Gastroenterol Disord. 2005. PMID: 15976740 Review.
-
Antiviral drug-induced nephrotoxicity.Am J Kidney Dis. 2005 May;45(5):804-17. doi: 10.1053/j.ajkd.2005.02.010. Am J Kidney Dis. 2005. PMID: 15861345 Review.
Cited by
-
Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B.Biomed Rep. 2021 Jan;14(1):12. doi: 10.3892/br.2020.1388. Epub 2020 Nov 12. Biomed Rep. 2021. PMID: 33235727 Free PMC article.
-
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.Antiviral Res. 2011 Aug;91(2):120-32. doi: 10.1016/j.antiviral.2011.05.003. Epub 2011 May 12. Antiviral Res. 2011. PMID: 21600932 Free PMC article.
-
Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency.Intern Med. 2019 Mar 15;58(6):821-825. doi: 10.2169/internalmedicine.1698-18. Epub 2018 Oct 17. Intern Med. 2019. PMID: 30333420 Free PMC article.
-
Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil.World J Hepatol. 2010 Dec 27;2(12):442-6. doi: 10.4254/wjh.v2.i12.442. World J Hepatol. 2010. PMID: 21191520 Free PMC article.
-
Discovery and development of anti-HBV agents and their resistance.Molecules. 2010 Aug 27;15(9):5878-908. doi: 10.3390/molecules15095878. Molecules. 2010. PMID: 20802402 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical